These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2174509

  • 1. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
    Mosberg HI, Heyl DL, Haaseth RC, Omnaas JR, Medzihradsky F, Smith CB.
    Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509
    [Abstract] [Full Text] [Related]

  • 2. Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity.
    Mosberg HI, Omnaas JR, Medzihradsky F, Smith CB.
    Life Sci; 1988 Dec; 43(12):1013-20. PubMed ID: 2845204
    [Abstract] [Full Text] [Related]

  • 3. Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide.
    Heyl DL, Omnaas JR, Sobczyk-Kojiro K, Medzihradsky F, Smith CB, Mosberg HI.
    Int J Pept Protein Res; 1991 Mar; 37(3):224-9. PubMed ID: 1651290
    [Abstract] [Full Text] [Related]

  • 4. Modification of the Phe3 aromatic moiety in delta receptor-selective dermorphin/deltorphin-related tetrapeptides. Effects on opioid receptor binding.
    Heyl DL, Mosberg HI.
    Int J Pept Protein Res; 1992 May; 39(5):450-7. PubMed ID: 1330964
    [Abstract] [Full Text] [Related]

  • 5. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.
    Haaseth RC, Sobczyk-Kojiro K, Medzihradsky F, Smith CB, Mosberg HI.
    Int J Pept Protein Res; 1990 Aug; 36(2):139-46. PubMed ID: 2177042
    [Abstract] [Full Text] [Related]

  • 6. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL, Schmitter SJ, Bouzit H, Johnson TW, Hepp AM, Kurtz KR, Mousigian C.
    Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
    [Abstract] [Full Text] [Related]

  • 7. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S, Corbett AD, Amiche M, Delfour A, Nicolas P, Kosterlitz HW.
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [Abstract] [Full Text] [Related]

  • 8. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
    Hruby VJ, Toth G, Gehrig CA, Kao LF, Knapp R, Lui GK, Yamamura HI, Kramer TH, Davis P, Burks TF.
    J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
    [Abstract] [Full Text] [Related]

  • 9. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M, Sagan S, Mor A, Delfour A, Nicolas P.
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [Abstract] [Full Text] [Related]

  • 10. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
    Toth G, Russell KC, Landis G, Kramer TH, Fang L, Knapp R, Davis P, Burks TF, Yamamura HI, Hruby VJ.
    J Med Chem; 1992 Jun 26; 35(13):2384-91. PubMed ID: 1320122
    [Abstract] [Full Text] [Related]

  • 11. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N, Milanov P, Vezenkov L, Pajpanova T, Naydenova E.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):249-56. PubMed ID: 15364002
    [Abstract] [Full Text] [Related]

  • 12. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Omnaas JR, Lomize A, Heyl DL, Nordan I, Mousigian C, Davis P, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4384-91. PubMed ID: 7996550
    [Abstract] [Full Text] [Related]

  • 13. Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions.
    Chandrakumar NS, Stapelfeld A, Beardsley PM, Lopez OT, Drury B, Anthony E, Savage MA, Williamson LN, Reichman M.
    J Med Chem; 1992 Aug 07; 35(16):2928-38. PubMed ID: 1323677
    [Abstract] [Full Text] [Related]

  • 14. Receptor binding and biological activity of bivalent enkephalins.
    Costa T, Wüster M, Herz A, Shimohigashi Y, Chen HC, Rodbard D.
    Biochem Pharmacol; 1985 Jan 01; 34(1):25-30. PubMed ID: 2981528
    [Abstract] [Full Text] [Related]

  • 15. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Lomize AL, Wang C, Kroona H, Heyl DL, Sobczyk-Kojiro K, Ma W, Mousigian C, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4371-83. PubMed ID: 7996549
    [Abstract] [Full Text] [Related]

  • 16. [D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptors.
    Toth G, Kramer TH, Knapp R, Lui G, Davis P, Burks TF, Yamamura HI, Hruby VJ.
    J Med Chem; 1990 Jan 09; 33(1):249-53. PubMed ID: 2153205
    [Abstract] [Full Text] [Related]

  • 17. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 18. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position.
    Schiller PW, Nguyen TM, Maziak LA, Wilkes BC, Lemieux C.
    J Med Chem; 1987 Nov 14; 30(11):2094-9. PubMed ID: 2822930
    [Abstract] [Full Text] [Related]

  • 19. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E, Tóth G, Benyhe S, Tourwe D, Péter A, Tömböly C, Borsodi A.
    Neurosignals; 2005 Nov 14; 14(6):317-28. PubMed ID: 16772734
    [Abstract] [Full Text] [Related]

  • 20. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH, Davis P, Hruby VJ, Burks TF, Porreca F.
    J Pharmacol Exp Ther; 1993 Aug 14; 266(2):577-84. PubMed ID: 8394911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.